X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs WYETH LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS WYETH LTD J.B.CHEMICALS/
WYETH LTD
 
P/E (TTM) x 14.8 27.7 53.4% View Chart
P/BV x 2.3 5.3 43.8% View Chart
Dividend Yield % 0.2 1.3 13.0%  

Financials

 J.B.CHEMICALS   WYETH LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
WYETH LTD
Mar-13
J.B.CHEMICALS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs3181,044 30.5%   
Low Rs200818 24.4%   
Sales per share (Unadj.) Rs148.0298.6 49.6%  
Earnings per share (Unadj.) Rs19.157.2 33.3%  
Cash flow per share (Unadj.) Rs23.958.4 41.0%  
Dividends per share (Unadj.) Rs0.5017.00 2.9%  
Dividend yield (eoy) %0.21.8 10.6%  
Book value per share (Unadj.) Rs128.9249.5 51.7%  
Shares outstanding (eoy) m84.8222.72 373.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.1 56.1%   
Avg P/E ratio x13.616.3 83.4%  
P/CF ratio (eoy) x10.815.9 67.8%  
Price / Book Value ratio x2.03.7 53.8%  
Dividend payout %2.629.7 8.8%   
Avg Mkt Cap Rs m21,95121,157 103.8%   
No. of employees `0002.70.5 555.7%   
Total wages/salary Rs m1,841400 460.3%   
Avg. sales/employee Rs Th4,590.913,787.4 33.3%   
Avg. wages/employee Rs Th673.4813.0 82.8%   
Avg. net profit/employee Rs Th592.12,643.3 22.4%   
INCOME DATA
Net Sales Rs m12,5516,783 185.0%  
Other income Rs m542353 153.6%   
Total revenues Rs m13,0937,136 183.5%   
Gross profit Rs m2,0551,617 127.0%  
Depreciation Rs m41227 1,550.4%   
Interest Rs m966 1,740.0%   
Profit before tax Rs m2,0881,938 107.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m469632 74.2%   
Profit after tax Rs m1,6191,301 124.5%  
Gross profit margin %16.423.8 68.7%  
Effective tax rate %22.532.6 68.9%   
Net profit margin %12.919.2 67.3%  
BALANCE SHEET DATA
Current assets Rs m7,7786,984 111.4%   
Current liabilities Rs m4,3582,056 212.0%   
Net working cap to sales %27.272.6 37.5%  
Current ratio x1.83.4 52.5%  
Inventory Days Days5599 55.1%  
Debtors Days Days8024 334.3%  
Net fixed assets Rs m5,713244 2,338.4%   
Share capital Rs m170227 74.6%   
"Free" reserves Rs m10,5475,441 193.8%   
Net worth Rs m10,9375,668 193.0%   
Long term debt Rs m025 0.0%   
Total assets Rs m15,5747,901 197.1%  
Interest coverage x22.8353.3 6.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 93.9%   
Return on assets %11.016.5 66.6%  
Return on equity %14.822.9 64.5%  
Return on capital %20.034.0 58.6%  
Exports to sales %48.70.2 22,329.7%   
Imports to sales %7.136.3 19.5%   
Exports (fob) Rs m6,11515 41,316.9%   
Imports (cif) Rs m8892,465 36.0%   
Fx inflow Rs m6,16915 40,585.5%   
Fx outflow Rs m1,2852,677 48.0%   
Net fx Rs m4,884-2,662 -183.5%   
CASH FLOW
From Operations Rs m1,397923 151.3%  
From Investments Rs m-320317 -101.1%  
From Financial Activity Rs m-1,196-481 248.6%  
Net Cashflow Rs m-102759 -13.5%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 51.1 0.6%  
Indian inst/Mut Fund % 3.4 11.3 30.0%  
FIIs % 3.9 7.2 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 30.4 121.7%  
Shareholders   30,437 21,978 138.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   VENUS REMEDIES  SHASUN PHARMA  SANOFI INDIA  FDC LTD.  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and FMCG sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 21, 2018 12:57 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS